Warfarin therapy
234 results
167 - 234
Acute coronary syndrome 
Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks: Cochrane systematic review- Evaluation of thrombophilia
- Antithrombotic agents in primary health care
- Deep vein thrombosis
- Anticoagulant therapy for deep vein thrombosis (DVT) in pregnancy: Cochrane systematic review
- Haemostatic therapies for stroke due to acute, spontaneous intracerebral haemorrhage
- Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
- Anticoagulation therapy versus placebo for pulmonary hypertension
Anticoagulation reversal with vitamin K doesn't reduce bleeding- Coumadin + aspirin no better than aspirin alone for PAD
- Oral rivaroxaban as effective as standard therapy for treatment of acute PE
- ACCP 2016: updated guidelines for VTE
- Takotsubo cardiomyopathy
- Rivaroxaban effective for acute DVT (EINSTEIN)
- Slightly lower risk of major bleeds with apixaban (NNT = 83); no difference in efficacy
- Management of acute atrial fibrillation
- Chronic heart failure
- Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack
- Anticoagulants for non-rheumatic atrial fibrillation and a history of stroke or transient ischaemic attacks
- Vitamin K antagonists versus antiplatelet therapy after transient ischaemic attack or minor ischaemic stroke of presumed arterial origin: Cochrane systematic review
- Updated American College of Chest Physicians guideline on antithrombotic therapy for venous thromboembolism
- Antiplatelet agents and anticoagulants for hypertension
- Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism
- Acute heart failure and pulmonary oedema
- Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation
- Smoking cessation
- 2023 American Geriatric Society update on potentially inappropriate medication use in the elderly (Beers List)
- Adverse effects of amiodarone
- ACC/AHA guidelines for atrial fibrillation
- Safe use of non-steroidal anti-inflammatory drugs (NSAIDs)
- Pentasaccharides for the treatment of deep vein thrombosis
- ACCP guidelines for antithrombotics in atrial fibrillation
- Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty: Cochrane systematic review
- Transient ischaemic attack (TIA)
- Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation
- Aspirin is no different than other anticoagulants for VTE prevention after joint replacement surgery
- For atrial fibrillation with ACS or PCI, apixaban plus clopidogrel (without aspirin) is preferred (AUGUSTUS)
- Clostridioides difficile diarrhoea
- Interventions for preventing thrombosis in solid organ transplant recipients
- Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis
- Drugs used in alcohol dependence
- Electrical cardioversion
- D-dimer can identify high-risk group for extended anticoagulation (PROLONG)
- Preoperative assessment
- Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing minor oral surgery or dental extractions
- Cerebral infarction (ischaemic stroke)
- Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment
- The DOAC score determines bleeding risk for patients with atrial fibrillation who take a direct-acting oral anticoagulant
- Antitubercular medication in ambulatory care
- Prevention of atrial fibrillation
- Antiplatelet and anticoagulation for patients with prosthetic heart valves
- Treatment of dyslipidaemias
- Non-steroid agents for idiopathic pulmonary fibrosis: Cochrane systematic review
- Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end‐stage kidney disease
- Use of medication during pregnancy